Total n (%)a | Definitive n (%) | Empiric n (%) | Prophylactic n (%) | |
---|---|---|---|---|
Group size (N) | 185 | 56 | 127 | 2 |
Age (median years) | 75.5 | 78.4 | 72.7 | 75.0 |
Gender (male) | 83 (45%) | 30 (54%) | 52 (41%) | 1 (50%) |
Total # comorbidities of interest | 268 | 83 | 183 | 2 |
Average # comorbidities per patient | 1.45 | 1.48 | 1.44 | 1.00 |
Chronic Obstructive Pulmonary Disorder | 25 | 8 | 16 | 1 |
Hypertension | 102 | 36 | 66 | 0 |
Diabetes Mellitus | 66 | 23 | 43 | 0 |
Malignancy (any, active) | 51 | 9 | 41 | 1 |
Hemodialysis | 25 | 6 | 19 | 0 |
None | 28 | 7 | 20 | 1 |
Outcome | ||||
Length of hospital days (median days) | 14.0 | 14.5 | 14.0 | 15.0 |
Mortality | 42 (23%) | 10 (18%) | 32 (25%) | 0 (0%) |
Cases with same recurrent infection within 30 days of discharge | 14 (8%) | 2 (4%) | 12 (9%) | 0 (0%) |
Duration of therapy (median days) | 6.5 | 7.0 | 5.0 | 11.0 |
Site of infection for PARA request | ||||
Respiratory | 145 | 30 | 113 | 2 |
Blood | 18 | 8 | 10 | 0 |
Gastrointestinal | 1 | 1 | 0 | 0 |
Genitourinary | 39 | 24 | 15 | 0 |
Wound/surgical site | 2 | 1 | 1 | 0 |